Bicara Therapeutics Inc. (BCAX)
NASDAQ: BCAX · Real-Time Price · USD
21.56
-0.13 (-0.60%)
At close: Jun 15, 2026, 4:00 PM EDT
21.99
+0.43 (1.99%)
After-hours: Jun 15, 2026, 5:58 PM EDT
Bicara Therapeutics Market Cap
Bicara Therapeutics has a market cap or net worth of $1.42 billion as of June 15, 2026. Its market cap has increased by 180.81% in one year.
Market Cap
1.42B
Enterprise Value
878.26M
1-Year Change
180.81%
Ranking
Category
Stock Price
$21.56
Market Cap Chart
Since the IPO on September 13, 2024, Bicara Therapeutics's market cap has increased from $931.70M to $1.42B, an increase of 52.04%. That is a compound annual growth rate of 26.99%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 15, 2026 | 1.42B | 53.64% |
| Dec 31, 2025 | 921.98M | -2.74% |
| Dec 31, 2024 | 947.92M | 1.74% |
| Sep 13, 2024 | 931.70M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Capricor Therapeutics | 1.49B |
| Immunocore Holdings | 1.47B |
| Novavax | 1.46B |
| SELLAS Life Sciences Group | 1.46B |
| Vir Biotechnology | 1.45B |
| GH Research | 1.45B |
| UroGen Pharma | 1.45B |
| AtaiBeckley | 1.44B |